Ignite Creation Date:
2025-12-25 @ 1:26 AM
Ignite Modification Date:
2025-12-28 @ 12:05 AM
Study NCT ID:
NCT06054893
Status:
RECRUITING
Last Update Posted:
2025-10-07
First Post:
2023-09-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Find Out How BIIB141 (Omaveloxolone) is Processed in the Body and to Learn More About Its Safety in Participants With Friedreich's Ataxia Aged 2 to 15 Years Old
Sponsor:
Biogen
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-07-01
Start Date Type:
ACTUAL
Primary Completion Date:
2030-02-21
Primary Completion Date Type:
ESTIMATED
Completion Date:
2030-02-21
Completion Date Type:
ESTIMATED
First Submit Date:
2023-09-13
First Submit QC Date:
None
Study First Post Date:
2023-09-26
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-10-06
Last Update Post Date:
2025-10-07
Last Update Post Date Type:
ESTIMATED